Trial intelligence / Profile preview

Carvedilol vs Propranolol for Long-term Portal Pressure Reduction in Cirrhosis

KCT0000102Phase 4Recruiting

Sponsor
Chong Kun Dang
Start
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of carvedilol, propranolol in Portal Hypertension (PH), Cirrhosis, sponsored by Chong Kun Dang. Started Jul 2011; status: recruiting.

02

Drugs

carvedilolpropranolol
03

Conditions

Portal Hypertension (PH)Cirrhosis

Beyond the preview

Go deeper on KCT0000102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call